In a tumour setting, T cells become exhausted due to chronic antigen exposure leading to reduced effector function [loss of interleukin-2 (IL-2), tumour necrosis factor alpha (TNF-α) and Interferon-gamma (IFN-γ) production]. Here, IL2 is linked to neoplasm.